RIVN Peptides
50 mg vial
- Vendor score
- 80/100
- Effective vial price
- Not available
- Effective price per mg
- Not available
ORView VendorPurchase link pending destination approval.
GHK (basic, copper-free) is a peptide or related compound used in skin and cosmetic research.
Also known as ghk · ghk (basic) · ghk basic · ghk tripeptide · ghk-basic
Research shortlist · Sep 12, 2026
These research selections use the same basis: 50 mg vial. The selections remain from Sep 12, 2026; each price below comes from its dated market observation.
50 mg vial
50 mg vial
50 mg vial
What it is
Gly-His-Lys is a tripeptide composed of glycine, L-histidine and L-lysine residues joined in sequence. It has a role as a metabolite, a chelator, a hepatoprotective agent and a vulnerary. The listed molecular formula is C14H24N6O4. PepGrades separately preserves the catalog category because a chemical identity record does not establish a use, outcome, or product quality.
This label describes the available research record, not whether the compound is safe or effective for an individual.
Research context
5 registered studies were found under this name in the current review. Each study still needs to be checked for the exact compound identity, population, endpoints, and results.
Search indexed research for this compound ↗Market context
GHK (basic, copper-free) is commonly sold or discussed for skin, hair, collagen, and cosmetic research. That describes market demand, not proof that the compound is safe or effective.
Market demand and online discussion do not establish product quality, safety, or effectiveness.Same format. Same amount.
1 of 1 formats had a qualifying research shortlist on Sep 12, 2026. Vendor counts below reflect the available price observations.
Vendor directory
Grades describe the vendor record overall. They are not a test result for every product.
| Vendor | Grade | Compared offers | In stock when checked | Lowest effective package | Profile |
|---|---|---|---|---|---|
| Polaris PeptidesVendor grade | Grade A- | 1 | 1 | $4050 mg vial · compare →Observed Sep 21, 2026 | View → |
| Rocky Mountain CompoundsVendor grade | Grade B+ | Not available | Not available | Not availableNo market observation | View → |
| Core PeptidesVendor grade | Grade B+ | 1 | 1 | $46.55Automatic quantity fixed amount off · listed $4950 mg vial · compare →Observed Sep 21, 2026 | View → |
| RIVN PeptidesVendor grade | Grade B+ | Not available | Not available | Not availableNo market observation | View → |
| Ion PeptidesVendor grade | Grade B | Not available | Not available | Not availableNo market observation | View → |
| RUOVendor grade | Grade B | Not available | Not available | Not availableNo market observation | View → |
| Atomik LabzNot enough information to grade | Not enough information to grade | Not available | Not available | Not availableNo market observation | View → |
| Skye PeptidesNot enough information to grade | Not enough information to grade | Not available | Not available | Not availableNo market observation | View → |
| TydesNot enough information to grade | Not enough information to grade | Not available | Not available | Not availableNo market observation | View → |
Sources and review
Last editorial review: Aug 30, 2026. Sources support the compound guide only and do not affect vendor grades.